Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,283,523
-
Share change
-
+3,378,399
-
Total reported value
-
$7,587,950,162
-
Put/Call ratio
-
72%
-
Price per share
-
$145.13
-
Number of holders
-
302
-
Value change
-
+$512,523,733
-
Number of buys
-
138
-
Number of sells
-
152
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2017
As of 31 Mar 2017 Jazz Pharmaceuticals plc - SHS USD (JAZZ) had 302 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 52,283,523 shares of stock of the company.
Largest 10 holders included PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JANUS CAPITAL MANAGEMENT LLC, Bank of New York Mellon Corp, WESTFIELD CAPITAL MANAGEMENT CO LP, ADAGE CAPITAL PARTNERS GP, L.L.C., CADIAN CAPITAL MANAGEMENT, LP, and FIL Ltd.
This table shows 302 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.